Live Breaking News & Updates on Mathilde Bohin|Page 20
Stay updated with breaking news from Mathilde bohin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IMPLANET Signs an Exclusive Distribution Contract for France With GLOBUS MEDICAL finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
for the annual shareholders meeting of May 27, 2021 Geneva, Switzerland, May 6, 2021 - 6:00pm CEST - GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurologic and autoimmune diseases, including multiple sclerosis, informs its shareholders that the Annual General Meeting will be held on Thursday May 27, 2021 at 9.30am at its head office, 3, chemin du Pré-Fleuri,1228 Plan-les-Ouates, Geneva, Switzerland. Based on article 27 of Ordinance 3 on Measures to combat the Coronavirus of 19 June 2020 (COVID- 19 Ordinance 3, status as of May 1st, 2021), the Board of Directors has decided that shareholders of the Company may exercise their rights at this Ordinary General Meeting exclusively through the Independent Proxy. This measure allows the Company to hold the Ordinary General Meeting as planned despite the pandemic. The conduct of the Ordinary General Meeting remains subject to additional measures ....
GeNeuro: Availability of Documents and Information for the Annual Shareholders Meeting of May 27, 2021 Regulatory News: GeNeuro (Euronext Paris: CH0308403085 GNRO), a biopharmaceutical company developing new treatments for neurologic and autoimmune diseases, including multiple sclerosis, informs its shareholders that the Annual General Meeting will be held on Thursday May 27, 2021 at 9.30am at its head office, 3, chemin du Pré-Fleuri, 1228 Plan-les-Ouates, Geneva, Switzerland. Based on article 27 of Ordinance 3 on Measures to combat the Coronavirus of 19 June 2020 (COVID-19 Ordinance 3, status as of May 1st, 2021), the Board of Directors has decided that shareholders of the Company may exercise their rights at this Ordinary General Meeting exclusively through the Independent Proxy. This measure allows the Company to hold the Ordinary General Meeting as planned despite the pandemic. The conduct of the Ordinary General Meeting remains subject to additional measures i ....
Live presentation of the AGM via web conference https://us02web.zoom.us/webinar/register/WN ykfVpnaURqCe3afIQ-Otsg Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 . Erytech Pharma S.A.April 28, 2021 GMT ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details Publication of Q1 2021 results on 4 May 2021 after market close Lyon (France) and Cambridge, MA (U.S.), April 29, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced its cash position at the end of the first quarter 2021 and that it will host its 2021 first quarter conference call and webcast on Wednesday, May 5, 2021, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights. ....